JYNARQUE: payments to doctors
Payments that named JYNARQUE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $7.4M
- Providers
- 11,987
- Transactions
- 78,189
- Average per transaction
- $94
The per-transaction average — $94 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,987 providers the average total is $614, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $6,685,468 | 90.9% |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $637,094 | 8.7% |
| Otsuka Pharmaceutical Co., Ltd. | $35,768 | 0.5% |